menu

Medical Program: New Findings on Triple-Negative Breast Cancer Treatments

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

New Findings on Triple-Negative Breast Cancer Treatments

Program Information
Recommended
New Findings on Triple-Negative Breast Cancer Treatments
RestartResume
Is immunotherapy truly a breakthrough in the context of triple-negative breast cancer? Here’s what the clinical trials and experts at ESMO are saying.
  • Sponsored by

  • Overview

    Known for his early drug development research for breast cancer, Dr. Giuseppe Curigliano joins Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about the latest research in treatment developments for triple-negative breast cancer as well as insights on what’s coming ahead on the future horizons for this cancer subtype. 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/13/19

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.